ONCOLYTICS BIOTECH INC's ticker is ONCY and the CUSIP is 682310875. A total of 35 filers reported holding ONCOLYTICS BIOTECH INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $13,491 | +116.7% | 5,189 | 0.0% | 0.01% | +133.3% |
| Q1 2023 | $6,227 | +3.8% | 5,189 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $6,000 | +20.0% | 5,189 | 0.0% | 0.00% | +50.0% |
| Q2 2022 | $5,000 | -68.8% | 5,189 | -50.0% | 0.00% | -33.3% |
| Q1 2022 | $16,000 | +128.6% | 10,378 | +100.0% | 0.00% | 0.0% |
| Q4 2021 | $7,000 | -36.4% | 5,189 | 0.0% | 0.00% | -40.0% |
| Q3 2021 | $11,000 | -21.4% | 5,189 | 0.0% | 0.01% | -28.6% |
| Q2 2021 | $14,000 | -30.0% | 5,189 | 0.0% | 0.01% | -41.7% |
| Q1 2021 | $20,000 | – | 5,189 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anson Funds Management LP | 5,302,036 | $11,558,438 | 2.33% |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 201,453 | $449,240 | 0.06% |
| BRAVE ASSET MANAGEMENT INC | 25,000 | $54,927 | 0.02% |
| Ausdal Financial Partners, Inc. | 20,000 | $43,600 | 0.01% |
| HEADINVEST, LLC | 11,534 | $24,106 | 0.01% |
| Cedar Mountain Advisors, LLC | 5,651 | $12,319 | 0.00% |
| Long Focus Capital Management, LLC | 40,000 | $87,200 | 0.00% |
| Banque Cantonale Vaudoise | 11,900 | $26 | 0.00% |
| OSAIC HOLDINGS, INC. | 9,712 | $21,173 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 33,485 | $72,997 | 0.00% |